Application of circRAPGEF51 to pituitary adenoma biomarkers
A pituitary adenoma and biomarker technology, applied in the field of natural ribonucleotides, can solve the problems of poor tumor curative effect, high recurrence rate, fast growth of tumor residual tissue, etc., and achieve the effect of institutional stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention. The present invention will be further described below in conjunction with specific embodiment
[0020] 1. Experimental materials, clinical samples: clinical samples: tissue samples of 19 cases of pituitary adenoma (8 cases of invasive pituitary adenoma, 9 cases of non-invasive pituitary adenoma) were provided by the Second Affiliated Hospital of Dalian Medical University.
[0021] Reagents: circRNA-RAPGEF5-1 screening primers were synthesized by Invitrogen;
[...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com